Piramal Enterprises Ltd’s Pharma Solutions business, a contract development and manufacturing organization, announced that it has entered into an agreement with G&W Laboratories Inc. to acquire its solid oral dosage drug product manufacturing facility located in Pennsylvania, USA, for $17.5 million.
Piramal Pharma Solutions to acquire manufacturing facility of G&W Laboratories in US
Date posted: Saturday 4 July 2020